- Home
- OPK vs BRSP Comparison
OPK vs BRSP Comparison
Compare OPK & BRSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | OPK | BRSP |
|---|---|---|
| Founded | 2006 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 921.2M | 738.7M |
| IPO Year | 2011 | 2017 |
Fundamental Metrics
Financial Performance| Metric | OPK | BRSP |
|---|---|---|
| Price | $1.45 | $5.54 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 3 | 3 |
| Target Price | $1.60 | ★ $6.50 |
| AVG Volume (30 Days) | ★ 2.7M | 941.9K |
| Earning Date | 04-28-2026 | 04-28-2026 |
| Dividend Yield | N/A | ★ 11.03% |
| EPS Growth | N/A | ★ 75.24 |
| EPS | N/A | ★ 0.03 |
| Revenue | ★ $606,879,000.00 | $330,587,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $4.24 | $17.54 |
| P/E Ratio | ★ N/A | $184.00 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.98 | $4.84 |
| 52 Week High | $1.60 | $6.17 |
Technical Indicators
Market Signals| Indicator | OPK | BRSP |
|---|---|---|
| Relative Strength Index (RSI) | 62.26 | 44.00 |
| Support Level | $1.25 | $5.46 |
| Resistance Level | $1.54 | $6.06 |
| Average True Range (ATR) | 0.06 | 0.12 |
| MACD | -0.01 | 0.00 |
| Stochastic Oscillator | 31.58 | 33.17 |
Price Performance
Historical ComparisonAbout OPK OPKO Health Inc.
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.
About BRSP BrightSpire Capital Inc.
BrightSpire Capital Inc is an internally-managed commercial real estate credit REIT focused on originating, acquiring, financing and managing a diversified portfolio of commercial real estate debt and net lease real estate investments predominantly in the United States. CRE debt investments consist of first mortgage loans with the objective of generating consistent risk-adjusted returns. The operating segments of the company are Senior and Mezzanine Loans and Preferred Equity, Net Leased and Other Real Estate, Corporate and Other. Geographically, the company generates revenue from the United States.